ID

15781

Descrizione

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01689662

collegamento

https://clinicaltrials.gov/show/NCT01689662

Keywords

  1. 13/06/16 13/06/16 -
Caricato su

13 giugno 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :


Non ci sono commenti

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Metastatic Renal Cell Carcinoma NCT01689662

Eligibility Metastatic Renal Cell Carcinoma NCT01689662

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. subject must be 18 years of age or older.
Descrizione

subjects must meet the following eligibility requirements to be enrolled in the study.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
2. subject must have known or strongly suspected metastatic renal cell carcinoma with at least one target lesion as identified by ultrasonography, mri, or ct.
Descrizione

metastatic renal cell carcinoma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0278678
3. subject must have good kidney function.
Descrizione

kidney function

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0232804
4. subject must provide written informed consent prior to enrollment.
Descrizione

written informed

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. subject is pregnant or breastfeeding.
Descrizione

subjects must be excluded if any of the following conditions are present:

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
2. subject is simultaneously participating in another investigational drug study, excluding the follow-up phase.
Descrizione

participating in another study

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
3. subject has received an investigational agent within 7 days prior to enrollment.
Descrizione

investigational agent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1875319
4. subject is unable to tolerate conditions for radionuclide imaging.
Descrizione

radionuclide imaging

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0034606
5. subject has been administered another radiopharmaceutical that would interfere with the assessment of technetium tc 99m ec20.
Descrizione

technetium tc 99m ec20

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0182638
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C1883272

Similar models

Eligibility Metastatic Renal Cell Carcinoma NCT01689662

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
1. subject must be 18 years of age or older.
boolean
C0001779 (UMLS CUI [1])
metastatic renal cell carcinoma
Item
2. subject must have known or strongly suspected metastatic renal cell carcinoma with at least one target lesion as identified by ultrasonography, mri, or ct.
boolean
C0278678 (UMLS CUI [1])
kidney function
Item
3. subject must have good kidney function.
boolean
C0232804 (UMLS CUI [1])
written informed
Item
4. subject must provide written informed consent prior to enrollment.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pregnancy or breast-feeding
Item
1. subject is pregnant or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
participating in another study
Item
2. subject is simultaneously participating in another investigational drug study, excluding the follow-up phase.
boolean
C2348568 (UMLS CUI [1])
investigational agent
Item
3. subject has received an investigational agent within 7 days prior to enrollment.
boolean
C1875319 (UMLS CUI [1])
radionuclide imaging
Item
4. subject is unable to tolerate conditions for radionuclide imaging.
boolean
C0034606 (UMLS CUI [1])
technetium tc 99m ec20
Item
5. subject has been administered another radiopharmaceutical that would interfere with the assessment of technetium tc 99m ec20.
boolean
C0182638 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C1883272 (UMLS CUI [1,3])

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial